127 related articles for article (PubMed ID: 19432575)
1. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):845-53. PubMed ID: 19432575
[TBL] [Abstract][Full Text] [Related]
2. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
[TBL] [Abstract][Full Text] [Related]
3. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
5. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
6. Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long?
Herbert A; Stein K; Bryant TN; Breen C; Old P
J Med Screen; 1996; 3(3):140-5. PubMed ID: 8946309
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the effect of occult invasive cancer on progress towards successful cervical screening.
Herbert A; Bryant TN; Campbell MJ; Smith J
J Med Screen; 1998; 5(2):92-8. PubMed ID: 9718528
[TBL] [Abstract][Full Text] [Related]
8. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
Herbert A; Smith JA
Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
[TBL] [Abstract][Full Text] [Related]
9. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
11. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
12. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers.
Castanon A; Ferryman S; Patnick J; Sasieni P
Cytopathology; 2012 Feb; 23(1):13-22. PubMed ID: 22243289
[TBL] [Abstract][Full Text] [Related]
13. Cervical screening: why young women should be encouraged to be screened.
Herbert A; Holdsworth G; Kubba AA
J Fam Plann Reprod Health Care; 2008 Jan; 34(1):21-5. PubMed ID: 18201402
[TBL] [Abstract][Full Text] [Related]
14. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
15. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
16. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Nauclér P; Arnheim-Dahlström L; Dillner J
BMJ; 2014 Jan; 348():g130. PubMed ID: 24435414
[TBL] [Abstract][Full Text] [Related]
17. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
[TBL] [Abstract][Full Text] [Related]
18. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.
Anttila A; Kotaniemi-Talonen L; Leinonen M; Hakama M; Laurila P; Tarkkanen J; Malila N; Nieminen P
BMJ; 2010 Apr; 340():c1804. PubMed ID: 20423964
[TBL] [Abstract][Full Text] [Related]
19. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.
Dillner J; Rebolj M; Birembaut P; Petry KU; Szarewski A; Munk C; de Sanjose S; Naucler P; Lloveras B; Kjaer S; Cuzick J; van Ballegooijen M; Clavel C; Iftner T;
BMJ; 2008 Oct; 337():a1754. PubMed ID: 18852164
[TBL] [Abstract][Full Text] [Related]
20. Invasive cervical cancer in Southampton and South West Hampshire: effect of introducing a comprehensive screening programme.
Herbert A; Breen C; Bryant TN; Hitchcock A; Macdonald H; Millward-Sadler GH; Smith J
J Med Screen; 1996; 3(1):23-8. PubMed ID: 8861047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
